|

Allopurinol Clinical Trials

5 actively recruiting trials across 3 locations

Also known as: Aloprim, Zyloprim

Pipeline

Phase 2: 2Phase 3: 2Phase 4: 1

Top Sponsors

  • dr. M.J.N.L. Benders1
  • VA Office of Research and Development1
  • Massachusetts General Hospital1
  • M.D. Anderson Cancer Center1
  • Crystalys Therapeutics1

Indications

  • Gout2
  • Heart Disease2
  • Arthritis2
  • Neuroprotection1
  • Resistant Hypertension1

Birmingham, Alabama2 trials

A Study of Dotinurad Versus Allopurinol in Participants With Gout

University of Alabama at Birmingham

Phase 3
Allopurinol Improves Heart Function in African Americans With Resistant Hypertension

Birmingham VA Medical Center, Birmingham, AL

Phase 2

Other1 trial

Cerebrum and Cardiac Protection With Allopurinol in Neonates With Critical Congenital Heart Disease Requiring Cardiac Surgery With Cardiopulmonary Bypass
Phase 3

South Birmingham, Alabama1 trial

Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout

The University of Alabama at Birmingham

Phase 4

Houston, Texas1 trial

Time-limited Triplet Combination of Pirtobrutinib, Venetoclax, and Obinutuzumab for Patients With Treatment-naïve Chronic Lymphocytic Leukemia (CLL) or Richter Transformation (RT)

M D Anderson Cancer Center

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.